SRTS Sensus Healthcare Inc
981
$3.81
$0.16
(4.38%)
| Watchers | 981 |
| 52-Wk Low | $1.79 |
| 52-Wk High | $5.38 |
| Market Cap | $59.84M |
| Volume | 91,131.00 |
| 52-Wk High | $5.38 |
| 52-Wk Low | $1.79 |
Sensus Healthcare (NASDAQ:SRTS) Share Price Passes Below Fifty Day Moving Average of $3.92Zolmax • about 1 month ago
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report)'s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.92 and...
Share to Feed
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 65,800 shares, an...
Management will discuss its new Fair Deal Agreement for its SRT-100 Vision IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th BOCA RATON, Fla., March 14, 2024...
New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company's booth generated a record-high...
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy...
Maxim Group analyst Anthony Vendetti has maintained their bullish stance on SRTS stock, giving a Buy rating yesterday. Anthony Vendetti has given h...
Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript...
Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditionsIntroduces recurring revenue model for the SRT-100 Vision (IG-SRT...
BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammatory diseases BOCA RATON, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE...